Published in Microvasc Res on March 09, 2009
Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr Protein Pept Sci (2011) 1.37
mTOR signaling in cancer cell motility and tumor metastasis. Crit Rev Eukaryot Gene Expr (2010) 1.13
Alteration of cell-cell junctions in cultured human lymphatic endothelial cells with inflammatory cytokine stimulation. Lymphat Res Biol (2014) 1.13
Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression. Neoplasia (2012) 0.98
Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels. PLoS One (2011) 0.96
Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis. Microcirculation (2016) 0.91
Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis. PLoS One (2014) 0.82
Cell invasion in the spheroid sprouting assay: a spatial organisation analysis adaptable to cell behaviour. PLoS One (2014) 0.81
IL-17A potentiates TNFα-induced secretion from human endothelial cells and alters barrier functions controlling neutrophils rights of passage. Pflugers Arch (2013) 0.79
Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment. Arthritis Res Ther (2012) 0.79
The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis. Cell Mol Gastroenterol Hepatol (2016) 0.75
Neutralizing Anti-IL20 Antibody Treatment Significantly Modulates Low Grade Inflammation without Affecting HbA1c in Type 2 Diabetic db/db Mice. PLoS One (2015) 0.75
IL-20 Signaling in Activated Human Neutrophils Inhibits Neutrophil Migration and Function. J Immunol (2017) 0.75
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell (2004) 4.12
Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci U S A (2002) 2.68
Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell (2002) 1.71
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood (2009) 1.50
Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation. Curr Pharmacogenomics Person Med (2011) 1.49
Ets 1 is expressed in capillary blood vessels but not in lymphatics. J Pathol (2003) 1.48
alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro. Angiogenesis (2003) 1.48
Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol (2003) 1.39
Microscopy: an art? Nat Rev Mol Cell Biol (2002) 1.38
Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span. Am J Pathol (2004) 1.35
VEGF is a chemoattractant for FGF-2-stimulated neural progenitors. J Cell Biol (2003) 1.34
Adipocyte and adipogenesis. Eur J Cell Biol (2013) 1.27
Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis. Proc Natl Acad Sci U S A (2012) 1.23
Human lymphatic endothelial cells express multiple functional TLRs. J Immunol (2008) 1.18
VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy. Proc Natl Acad Sci U S A (2009) 1.16
Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clin Cancer Res (2004) 1.10
Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation (2003) 1.10
The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review. Stem Cells Dev (2015) 1.10
IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs. Proc Natl Acad Sci U S A (2007) 1.07
Vitamin D is positively associated with sperm motility and increases intracellular calcium in human spermatozoa. Hum Reprod (2011) 1.04
Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol (2002) 1.03
Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical. Cancer Res (2005) 1.00
Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Nutr Rev (2013) 1.00
Downregulation of vascular endothelial-cadherin expression is associated with an increase in vascular tumor growth and hemorrhagic complications. Thromb Haemost (2005) 0.99
Nerve growth factor activates aorta endothelial cells causing PI3K/Akt- and ERK-dependent migration. Pflugers Arch (2005) 0.98
Circulating and imaging markers for angiogenesis. Angiogenesis (2008) 0.98
Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C. J Cell Sci (2004) 0.97
Membrane-type-1 matrix metalloproteinase confers tumorigenicity on nonmalignant epithelial cells. Oncogene (2005) 0.94
Lymphangiogenesis in human gynaecological cancers. Angiogenesis (2005) 0.94
Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis. Cancer Res (2002) 0.93
Lymphatic dissemination of tumour cells and the formation of micrometastases. Lancet Oncol (2002) 0.92
Establishing a public umbilical cord blood stem cell bank for South Africa: an enquiry into public acceptability. Stem Cell Rev (2013) 0.91
Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro. Exp Cell Res (2002) 0.91
Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro. Exp Cell Res (2003) 0.90
Anti-PD-L1 for metastatic triple-negative breast cancer. Lancet Oncol (2015) 0.90
Nitric oxide signalling in salivary glands. J Oral Pathol Med (2002) 0.89
A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents. Angiogenesis (2009) 0.88
Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study. BMC Med Genet (2013) 0.87
Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine. Drug Metab Rev (2014) 0.86
Lymphangiogenesis and tumor metastasis. Thromb Haemost (2003) 0.86
Bovine microvascular endothelial cells immortalized with human telomerase. J Cell Biochem (2006) 0.85
The Consumer Protection Act: no-fault liability of health care providers. S Afr Med J (2011) 0.85
Increased intracellular calcium is required for neurite outgrowth induced by a synthetic peptide ligand of NCAM. FEBS Lett (2002) 0.83
Opportunities and barriers to establishing a cell therapy programme in South Africa. Stem Cell Res Ther (2013) 0.83
Visualizing function in the tumor-associated lymphatic system. Lymphat Res Biol (2004) 0.82
Hemangiomas - current therapeutic strategies. Int J Dev Biol (2011) 0.82
Priority pharmacogenetics for the African continent: focus on CYP450. Pharmacogenomics (2014) 0.81
The human SH-SY5Y neuroblastoma cell-line expresses a functional P2X7 purinoceptor that modulates voltage-dependent Ca2+ channel function. J Neurochem (2002) 0.81
Inhibition of hemangioma development in a syngeneic mouse model correlates with bcl-2 suppression and the inhibition of Akt kinase activity. Angiogenesis (2011) 0.81
IL-17A potentiates TNFα-induced secretion from human endothelial cells and alters barrier functions controlling neutrophils rights of passage. Pflugers Arch (2013) 0.79
Characterization of a novel NCAM ligand with a stimulatory effect on neurite outgrowth identified by screening a combinatorial peptide library. Eur J Neurosci (2002) 0.79
Mutations in C-C chemokine receptor type 5 (CCR5) in South African individuals. Int J Infect Dis (2013) 0.78
Increased angiostatin levels in bronchoalveolar lavage fluids from ARDS patients and from human volunteers after lung instillation of endotoxin. Thromb Haemost (2002) 0.78
IL-27 inhibits lymphatic endothelial cell proliferation by STAT1-regulated gene expression. Microcirculation (2013) 0.78
Cardiovascular pharmacogenetics. Pharmacol Ther (2011) 0.78
Homing properties of mesenchymal stromal cells. Expert Opin Biol Ther (2014) 0.78
Ethical, legal and social issues in the context of the planning stages of the Southern African Human Genome Programme. Med Law (2012) 0.77
Lymphatic endothelial cells: establishment of primaries and characterization of established lines. Methods Mol Biol (2009) 0.77
Non-genomic effects of vitamin D in human spermatozoa. Steroids (2012) 0.77
Haemangiomas are formed by cells expressing high levels of alphavbeta3 integrin and lacking acetylated LDL uptake. J Pathol (2004) 0.76
Lymphangiogenesis and tumour metastasis. Novartis Found Symp (2004) 0.76
Quantitative plasma analysis using automated online solid-phase extraction with column switching LC-MS/MS for characterising cytochrome P450 2D6 and 2C19 metabolism. J Sep Sci (2011) 0.76
Tetracycline-regulated expression of VEGF-A in beta cells induces angiogenesis: improvement of engraftment following transplantation. Cell Transplant (2006) 0.76
Polymorphisms in the endothelial nitric oxide synthase gene and the tendency for aneurysm rupture. J Neurosurg (2005) 0.75
Pilot social feasibility study for the establishment of a public human umbilical cord blood stem cell bank in South Africa. Stem Cell Rev (2012) 0.75
Active-site inactivated FVIIa decreases thrombosis and necrosis in a random skin flap model of acute ischemia. J Surg Res (2004) 0.75
Mixed arterio-venous insufficiency in random skin flaps in the rat: is the application of medicinal leeches beneficial? J Surg Res (2008) 0.75
HLA typing: Conventional techniques v. next-generation sequencing. S Afr Med J (2015) 0.75
Understanding the Implications of Mitochondrial DNA Variation in the Health of Black Southern African Populations: The 2014 Workshop. Hum Mutat (2015) 0.75
Could we offer mitochondrial donation or similar assisted reproductive technology to South African patients with mitochondrial DNA disease? S Afr Med J (2016) 0.75
Hypoxic preconditioning increases skin oxygenation and viability but does not alter VEGF expression or vascular density. High Alt Med Biol (2008) 0.75
Air pollution, climate change, and health. Lancet Oncol (2015) 0.75